BridgeMD
New treatment option for Chronic Pain
Official title Whole-Body Photobiomodulation and Chronic Pain Trial
ClinicalTrials.gov ID: NCT05069363
What this study is testing
- What it's testing
- Chronic pain is a common long-term condition that can affect any area throughout the body. Individuals suffering with chronic pain often have associated fatigue, sleep and mood disturbances.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Patients eligible for the trial must comply with all of the following:
- Currently diagnosed or receiving treatment for a widespread chronic pain condition, including but not limited to:
- Axial pain of any origin
- Polyathralgia of any origin
- Myofascial pain of any origin
You likely can't join if
- Pregnancy
- Severe skin diseases (e.g. skin cancer, severe eczema, dermatitis, or psoriasis)
- Body weight ≥136kg, as per manufacturer instructions [see Appendix 3]
- Uncontrolled co-morbidities (e.g. uncontrolled diabetes defined as HbA1c \>69mmol/mol, decompensated heart failure, major psychiatric disturbance...
- Use of systemic corticosteroid therapy including oral prednisolone or corticosteroid injections within the preceding 6 months as recommended by the...
- Known active malignancy
See the full eligibility criteria
- Patients eligible for the trial must comply with all of the following:
- Currently diagnosed or receiving treatment for a widespread chronic pain condition, including but not limited to:
- Axial pain of any origin
- Polyathralgia of any origin
- Myofascial pain of any origin
- A diagnosis of chronic widespread pain or FM
- Able to provide informed written consent
- ≥18 years
- Able to commit time to the trial treatment schedule of 6 weeks
- Score as low or moderate risk on the COVID-19 risk stratification tool - applicable for the duration of the pandemic
- Pregnancy
- Severe skin diseases (e.g. skin cancer, severe eczema, dermatitis, or psoriasis)
- Body weight ≥136kg, as per manufacturer instructions [see Appendix 3]
- Uncontrolled co-morbidities (e.g. uncontrolled diabetes defined as HbA1c \>69mmol/mol, decompensated heart failure, major psychiatric disturbance such as acute psychosis or suicidal ideation)
- Use of systemic corticosteroid therapy including oral prednisolone or corticosteroid injections within the preceding 6 months as recommended by the manufacturer; steroids are thought to inhibit the anti-inflammatory...
- Known active malignancy
- Inability to enter the NovoTHOR device or lie flat for 20 minutes (either due to physical reasons or other e.g. claustrophobia)
- Patients speaking a language for which an interpreter cannot be sought
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, United Kingdom
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.